This Week in Nature

Researchers in New York report in Nature that the epigenetic modification factors Parp1 and Tet2 are needed to regulate the epigenetic and chromatin status during somatic cell reprogramming to induced pluripotent stem cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Order Matters

Eye on iPS

This Week in PLOS

Retraction Time

Secrets of the Cell

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.